Due to the unprecedented disruption of health care services by the COVID-19 pandemic the American Society of Radiation Oncology ASTRO and the European Society for Radiotherapy and Oncology ESTRO identified an urgent need to issue practice recommendations for radiation oncologists treating head and neck cancer HNC in a time of heightened risk for patients and staff and of limited resources. Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: an ASTRO-ESTRO consensus statement.